Sylph Industries has appointed Sunil Amarchand Kalal as an Additional Executive Director effective July 4, 2026, subject to shareholder approval. The appointment aims to strengthen the company's leadership with expertise in corporate law and regulatory compliance. The Board of Directors approved the resolution during its meeting held on July 4, 2026, following the recommendation of the Nomination and Remuneration Committee.

Sunil Amarchand Kalal is an experienced Corporate Law and Trademark Consultant with over 20 years of expertise in corporate advisory, regulatory compliance, and business consultancy. His background includes advising private and public companies, listed entities, LLPs, and partnership firms on corporate laws, regulatory compliances, governance, restructuring, and intellectual property. He is recognized for delivering practical, business-oriented solutions while ensuring full compliance with applicable laws and regulatory frameworks.

The disclosure confirms that Kalal is not related to any existing directors of the company. Furthermore, he is not debarred from holding the office of Director by any order passed by the Securities and Exchange Board of India (SEBI) or any other authority. The appointment was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Key Details of Appointment

The company has submitted the necessary disclosures to BSE Limited, adhering to the regulatory requirements. The intimation was filed under the reference ISIN INE706F01021 and Scrip Code 511447.

Sylph Industries has accepted the resignation of Mrs. Divya Khandelwal as a Non-Executive Independent Director, effective from the close of business hours on July 6, 2026. The resignation follows a communication from the director citing personal reasons and other commitments that prevent her from devoting sufficient time to the company's affairs. The Board of Directors has noted the decision and placed on record its appreciation for her contributions during her tenure.

The disclosure was made to BSE Limited pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Mrs. Khandelwal confirmed that there are no material reasons for her resignation other than those stated in her resignation letter.

Resignation Details

The specific details regarding the change in directorship were outlined in the regulatory filing. Mrs. Divya Khandelwal (DIN: 08444385) submitted her formal resignation on July 4, 2026, which was subsequently accepted by the Board.

Mrs. Khandelwal currently holds a directorship at Bio Medica Laboratories Limited as an Independent Director but does not hold memberships on any committees. She requested the Board to file the necessary intimations and documents with the statutory authorities to give effect to her resignation.